@article{Romodanovsky_2021,<br/><span class="tab"></span> title={Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic},<br/><span class="tab"></span> volume={11},<br/><span class="tab"></span> ISSN={1991-2919},<br/><span class="tab"></span> url={http://dx.doi.org/10.30895/1991-2919-2021-11-1-6-15},<br/><span class="tab"></span> DOI={10.30895/1991-2919-2021-11-1-6-15},<br/><span class="tab"></span> number={1},<br/><span class="tab"></span> journal={The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products},<br/><span class="tab"></span> publisher={SCEEMP},<br/><span class="tab"></span> author={Romodanovsky,<br/><span class="tab"></span> D. P. and Khokhlov,<br/><span class="tab"></span> A. L. and Goryachev,<br/><span class="tab"></span> D. V.},<br/><span class="tab"></span> year={2021},<br/><span class="tab"></span> month=mar,<br/><span class="tab"></span> pages={6–15} }